Inhibikase Therapeutics, Inc. - Common Stock (IKT)

2.1050
+0.0450 (2.18%)
NASDAQ · Last Trade: May 11th, 1:45 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors